PM

Pankajini Mallick

Principal Scientist, Preclinical Development at Neurocrine Biosciences

Pankajini Mallick, Ph.D is a Principal Scientist at Neurocrine Biosciences with a strong background in drug metabolism and pharmacokinetics. Pankajini has extensive experience in developing models to support safety assessments of chemicals in vulnerable populations. Pankajini previously worked at ScitoVation as a Scientist and a Postdoctoral Fellow, focusing on in vitro toxicity studies. Pankajini conducted research at the University of Houston on drug metabolism and hepatotoxicity, and also has experience in drug development from their time at LUPIN LIMITED and Glenmark Pharmaceuticals. Pankajini holds a PhD in Pharmaceutics from the University of Houston.

Links

Previous companies

University of Houston logo
Lupin logo
ScitoVation logo

Timeline

  • Principal Scientist, Preclinical Development

    January, 2020 - present

View in org chart